MGB Biopharma’s focus is to further develop their completely new class of anti-infective medicine, starting with antibiotics based on Minor Groove Binder (MGBs) compounds. The Company’s experienced management team have dedicated their initial focus to the development of a new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria. In providing a new class of drug to the field of antibacterial resistance, based on a truly novel mechanism of action, MGB Biopharma are unique, in that a truly new class and novel MoA was last seen in the year 2000. There are many drugs used to treat bacterial infections, and generally they belong to classes which have been in use for several decades. Due to the rise in resistant strains of bacteria, several of these drugs are becoming less and less effective. The Company’s progress has been rapid, and our lead drug candidate, MGB-BP-3, is currently in Phase I clinical safety studies, which will reach completion at the end of 2015. MGB-BP-3 is just the first in our new exciting class of anti-infectives. MGB Biopharma commenced operations in 2010, and is funded by a syndicate of some of Scotland’s leading business angels, in co-operation with Scottish Enterprise.
View Top Employees from MGB Biopharma LimitedWebsite | http://www.mgb-biopharma.com |
Revenue | $4 million |
Funding | $7.4 million |
Employees | 7 (2 on RocketReach) |
Founded | 2010 |
Phone | +44 1698 464224 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology Research, Drug Stores & Pharmacies, Biotechnology, Gram-positive Anti-Infectives, Retail, Science and Engineering, Innovative Drug Development, Health Care, Preclinical & Clinical Studies, Medical Device, Clostridium difficile |
Web Rank | 34 Million |
Keywords | Mgb Biopharma., |
Competitors | Complexa Inc., Madam Therapeutics, OncoSynergy, Protalex, Inc., QureTech Bio AB |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular MGB Biopharma Limited employee's phone or email?
The MGB Biopharma Limited annual revenue was $4 million in 2023.
Chris Wardhaugh is the Chief Business Officer of MGB Biopharma Limited.
2 people are employed at MGB Biopharma Limited.
The NAICS codes for MGB Biopharma Limited are [32541, 3254, 325, 32].
The SIC codes for MGB Biopharma Limited are [283, 28].